Nicholas A.j. Botwood, Head of R&D, CMO at Syndax Pharmaceuticals Inc (SNDX), sold 65,515 shares at $18.00 ($1.2M) on 2026-06-11, disclosed to the SEC on 2026-06-12.
Scheduled sale ($1.2M) by Head of R&D, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 34,280 | $617K | 52.1% |
| 2 | $18.14 | 31,235 | $567K | 47.9% |
| Total | $18.07 avg | 65,515 | $1.2M | 100% |